ArticleJournal of biological engineering2025
Exploring of therapeutic potential of indirubin-loaded nanofibrous scaffolds for localized melanoma treatment.
Article in Journal of biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nanofibrous scaffolds have been established as capable platforms for localized drug delivery systems of skin cancer management. Our study aimed to develop an electrospun nanofibrous scaffold loaded with indirubin, a naturally occurring bisindole alkaloid found in plants that bear indigo, for efficient targeted chemotherapy. The scaffold was prepared from polyvinyl alcohol (PVA) and chitosan (CS), using the electrospinning process, and incorporated with indirubin. Additional experiments were conducted to evaluate the physicochemical properties, perform antioxidant assays, and analyze the release profile. The scaffolds’ anticancer activity was evaluated on human skin melanoma cells. The prepared indirubin-loaded PVA/CS scaffold exhibited nanofibers (NFs) with a nanoscale diameter, a defect-free, and homogeneous morphology. Infrared spectroscopy confirmed the successful incorporation of indirubin into the scaffold. The scaffold displayed a hydrophilic surface, sufficient mechanical strength, high porosity, and a high liquid absorption capacity. In addition, the incorporation of 15 wt% indirubin demonstrated notable antioxidant properties, and its release from the NFs occurred in a controlled and extended manner over approximately 72 h. Furthermore, the scaffold significantly declined cell viability and induced apoptosis in melanoma cells. It is believed that an indirubin-loaded PVA/CS nanofibrous scaffold holds promise as a valuable system for localized melanoma treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.